Fibroblast Growth Factor Receptor (FGFR) Inhibitors in Urothelial Cancer

Dysregulated fibroblast growth factor receptor (FGFR) signaling is associated with several cancers, including urothelial carcinoma. Preclinical studies with FGFR inhibitors have shown significant antitumor activity, which has led to clinical evaluation of multiple FGFR inhibitors. Recently, erdafiti...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncologist
Huvudupphovsmän: Garje, Rohan, An, Josiah, Obeidat, Mohammad, Kumar, Kranthi, Yasin, Hesham A., Zakharia, Yousef
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley & Sons, Inc. 2020
Ämnen:
Genitourinary Cancer
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7648343/
https://ncbi.nlm.nih.gov/pubmed/32790011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0334
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk